ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Citizens Commission on Human Rights Calls for Congressional Investigation into Psychiatric In-Patient Treatment, as Study Finds Suicide Risk High after Hospitalization for Depression or Attempted Suicide

Recent studies indicate patients discharged from psychiatric facilities are at greater risk for suicide than mental health patients not hospitalized, suggesting that psychiatric hospitalization itself may be a major risk factor. Antidepressants used as treatment are also linked to an increased risk of suicide.

Citizens Commission on Human Rights (CCHR) National Affairs Office is urging Congress to investigate after a new study has found that patients released from psychiatric hospitalization for depression or attempted suicide are at the highest risk of completing suicide in the days immediately following their hospital discharge.

Researchers examined all psychiatric hospitalizations for depression in Finland from 1996 to 2017, along with a follow-up period of two years after hospital discharge. They reported that the time frames with the greatest risks for suicide occurred in the first three days after discharge, followed by days 4 through 7. Of the patients who took their own lives within two years after discharge, 9% died during the first week after discharge, 23% during the first month.

“In this study, patients hospitalized for depression had extremely high risk of suicide during the first days after discharge,” wrote the study’s lead author, Kari Aaltonen, M.D., Ph.D. “Thereafter, incidence declined steeply but remained high.” The study was published in JAMA Psychiatry.

The findings are consistent with other research indicating that psychiatric hospitalization may not reduce the risk of repeat self-harm for some patients, but may instead increase it. 

Research has found that patients who have been discharged from psychiatric facilities seem to have a greater risk for suicide than mental health patients who have not been hospitalized; that the risk of suicide after discharge from psychiatric facilities is very high, especially in the weeks and months immediately after release; and that even many years after discharge, previously hospitalized psychiatric patients have suicide rates that are many times higher than in the general population. 

People who were admitted to a psychiatric facility against their will were even more likely to attempt suicide after discharge than mental health patients who were not forcibly admitted.

Concerning the psychiatric hospitalization of children, research has found that young people 12-24 years of age who were admitted to psychiatric facilities were at significantly higher risk for self-harm and death in the first three years after discharge when compared to young mental health patients who were not hospitalized.

All this research suggests that psychiatric hospitalization is a major risk factor for significantly worse outcomes for some patients. 

The antidepressants used in psychiatric treatment of depressed and suicidal patients have also been linked to suicidal behavior. Researchers conducting a 2019 re-analysis of safety summaries in the U.S. Food and Drug Administration (FDA) database found evidence that antidepressants significantly increase the suicide risk in adults with major depression. The rate of attempted suicide was found to be about 2.5 times higher in those who were given antidepressants in clinical trials than those who received a placebo.

Further evidence of a link between antidepressants and suicide is provided in a newly published study, which found that the suicide rate in the U.S. increased right along with the increase in antidepressant prescriptions over the three decades from 1990 to 2020.  

This was a time frame in which a key rationale for prescribing antidepressants – the unproven theory of a chemical (serotonin) imbalance in the brain – was popularized.

During the period of 1990-2010, there was significant coverage of the theory in psychiatric and pharmacological publications. At the same time, there was a rapid upswing in antidepressant prescriptions.

However, a landmark 2022 study found no scientific support for the theory, calling into question the prescribing of antidepressants. The spreading of that unproven theory by psychiatrists and the pharmaceutical industry led to the mass prescribing of antidepressants in the U.S. and worldwide. Today some 45 million Americans take antidepressants, over 2 million of them children under the age of 18.

Another new study has found that increased antidepressant prescribing is not associated with any reduction in sadness, worry or unhappiness in Western nations.

Due to the number of recent studies showing a potentially adverse relationship between the treatments given and the rate of suicide, the Citizens Commission on Human Rights National Affairs Office is calling for a Congressional investigation into the matter.

WARNING: Anyone wishing to discontinue or change the dose of an antidepressant or other psychiatric drug is cautioned to do so only under the supervision of a physician because of potentially dangerous withdrawal symptoms.

About the company: The Citizens Commission on Human Rights was co-founded in 1969 by members of the Church of Scientology and the late psychiatrist and humanitarian Thomas Szasz, M.D., recognized by many academics as modern psychiatry’s most authoritative critic, to eradicate abuses and restore human rights and dignity to the field of mental health.

Contact Info:
Name: Anne Goedeke
Email: Send Email
Organization: Citizens Commission on Human Rights, National Affairs Office
Address: Washington, DC
Website: http://www.cchrnational.org

Release ID: 89123519

If there are any problems, discrepancies, or queries related to the content presented in this press release, we kindly ask that you notify us immediately at error@releasecontact.com. Our responsive team will be available round-the-clock to address your concerns within 8 hours and take necessary actions to rectify any identified issues or support you with press release takedowns. Ensuring accurate and trustworthy information is our unwavering commitment.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.